ELEVAI Labs Inc

NASDAQ:ELABUnited States

NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

Elevai Labs, Inc. is a physician-dispensed skincare company. The Company conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. It produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical cord-derived mesenchymal stem cells (hUMSC) for its specialty physician-dispensed skincare product lines. It has integrated the use of stem cell exosomes into its initial product line: Elevai Post Treatment E-Series. The E-Series comprises two post-skincare procedure care products that target the face and neck, and upper chest regions. Its products include Empower and Enfinity serums. Empower is its after-treatment topical product that supports the appearance of healthy skin and promotes an even toned complexion.

Contact Information

Headquarters

120 Newport Center Drive, Ste 250NEWPORT BEACH, CA, United States 92660

Phone

---

Fax

302-636-5454

Executives

President, Chief Executive Officer, Director

Jordan Plews

Chief Financial Officer, Director

Graydon Bensler

Chief Marketing Officer

Brenda Buechler

Chief Medical Officer, Director

Hatem Abou-Sayed

Chief Commercial Officer

Christoph Kraneiss